InvestorsHub Logo
Followers 122
Posts 17458
Boards Moderated 0
Alias Born 01/06/2014

Re: Cardiologymd post# 293658

Saturday, 08/29/2020 3:21:01 PM

Saturday, August 29, 2020 3:21:01 PM

Post# of 430250

The statement is correct. 17 percent compared to baseline. Nothing to do with placebo group. Your thinking about this is incorrect


This has everything to do with the placebo group. If you do nothing (placebo), does LAP remain steady (0% increase) or does it increase by 107%?

EVAPORATE tells us the latter (107% increase).

When you compare the 17% decrease in the Vascepa arm, you can't compare that against Baseline, because that is an imaginary term/ number, since 'Baseline' isn't a constant. It went up by 107%.

You are driving at 17 MPH on a highway. A car is traveling in the opposite direction on the same highway at 107 MPH. Both travel in straight lines. In one hour, how far will the two cars be from each other?

The answer is 124 (17 + 107). Not 17 (17 + 0).

Yes, you will be 17 miles away from the starting point, but that is not the question. The question is how far the two cars are from each other, similarly to how much LAP improved by with using Vascepa in EVAPORATE. The other car (placebo arm) traveled 107 miles, it didn't stay at 0.

Others want to chime in? My last post today.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News